Home > Financial Ratios > NATCO PHARMA
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 9.7111.3063.7525.3716.03

What is the latest EV/EBIT ratio of NATCO PHARMA ?

The latest EV/EBIT ratio of NATCO PHARMA is 9.71 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar20249.71
Mar202311.30
Mar202263.75
Mar202125.37
Mar202016.03

How is EV/EBIT of NATCO PHARMA Trending?

Years EV/EBIT % Change
Mar2024 9.71
-14.07
Mar2023 11.3
-82.27
Mar2022 63.75
151.28
Mar2021 25.37
58.27
Mar2020 16.03 -

Other Financial Ratios of NATCO PHARMA


Compare EV/EBIT ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹17,436.3 Cr 10.2% 13.4% -23.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,788.0 Cr -0.6% 0.8% 10.5% Stock Analytics
DIVIS LABORATORIES ₹183,268.0 Cr 3.1% 3.8% 49.2% Stock Analytics
CIPLA ₹122,253.0 Cr 0.4% 2.5% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,914.0 Cr -0.2% 6.4% 20.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,921.0 Cr -0.6% 3.3% 0.1% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

10.2%

13.4%

-23.1%

SENSEX

-0.6%

3.1%

5.3%


You may also like the below Video Courses